News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
274,342 Results
Type
Article (14542)
Company Profile (281)
Press Release (259519)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (80539)
Career Advice (158)
Deals (13357)
Drug Delivery (36)
Drug Development (50784)
Employer Resources (32)
FDA (5780)
Job Trends (5276)
News (146064)
Policy (10248)
Tag
Academia (944)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21898)
ALS (65)
Alzheimer's disease (859)
Antibody-drug conjugate (ADC) (102)
Approvals (5808)
Artificial intelligence (125)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4692)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (233)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (155)
Cancer (1486)
Cardiovascular disease (116)
Career advice (139)
Career pathing (2)
CAR-T (118)
Cell therapy (334)
Cervical cancer (8)
Clinical research (41321)
Collaboration (548)
Compensation (258)
Complete response letters (13)
COVID-19 (1060)
CRISPR (42)
C-suite (165)
Cystic fibrosis (76)
Data (1531)
Denatured (12)
Depression (30)
Diabetes (140)
Diagnostics (1360)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (87)
Drug pricing (28)
Drug shortages (4)
Duchenne muscular dystrophy (90)
Earnings (30157)
Editorial (19)
Employer branding (4)
Employer resources (30)
Events (51841)
Executive appointments (464)
FDA (6481)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (502)
Gene editing (97)
Generative AI (11)
Gene therapy (254)
GLP-1 (369)
Government (1146)
Grass and pollen (2)
Guidances (22)
Healthcare (6858)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (93)
Indications (20)
Infectious disease (1129)
Inflammatory bowel disease (114)
Inflation Reduction Act (8)
Influenza (24)
Intellectual property (67)
Interviews (17)
IPO (7319)
IRA (11)
Job creations (875)
Job search strategy (133)
Kidney cancer (7)
Labor market (5)
Layoffs (210)
Leadership (3)
Legal (1446)
Liver cancer (33)
Lung cancer (206)
Lymphoma (101)
Machine learning (3)
Management (7)
Manufacturing (142)
MASH (53)
Medical device (2717)
Medtech (2718)
Mergers & acquisitions (6370)
Metabolic disorders (395)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (69)
Neuropsychiatric disorders (25)
Neuroscience (1271)
NextGen: Class of 2025 (2133)
Non-profit (984)
Now hiring (22)
Obesity (198)
Opinion (102)
Ovarian cancer (63)
Pain (43)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (130)
Patient recruitment (78)
Peanut (35)
People (25973)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14578)
Phase II (19201)
Phase III (12186)
Pipeline (816)
Policy (45)
Postmarket research (868)
Preclinical (6179)
Press Release (31)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (215)
Rare diseases (293)
Real estate (1447)
Recruiting (13)
Regulatory (8738)
Reports (15)
Research institute (966)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (60)
Series A (98)
Series B (64)
Service/supplier (1)
Sickle cell disease (40)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1985)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (10)
The Weekly (36)
Vaccines (222)
Venture capitalists (34)
Weight loss (114)
Women's health (16)
Worklife (2)
Date
Today (99)
Last 7 days (524)
Last 30 days (1534)
Last 365 days (19779)
2025 (6364)
2024 (20808)
2023 (22728)
2022 (27172)
2021 (28292)
2020 (23833)
2019 (17048)
2018 (12353)
2017 (13978)
2016 (12180)
2015 (14683)
2014 (10602)
2013 (7659)
2012 (7784)
2011 (7852)
2010 (7607)
Location
Africa (155)
Alabama (42)
Alaska (2)
Arizona (57)
Arkansas (5)
Asia (17676)
Australia (2984)
California (3895)
Canada (1149)
China (361)
Colorado (160)
Connecticut (157)
Delaware (102)
Europe (37811)
Florida (474)
Georgia (117)
Idaho (16)
Illinois (239)
India (10)
Indiana (98)
Iowa (2)
Japan (76)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (13)
Maryland (482)
Massachusetts (3137)
Michigan (74)
Minnesota (148)
Mississippi (1)
Missouri (26)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (15)
New Jersey (983)
New Mexico (12)
New York (1056)
North Carolina (555)
North Dakota (5)
Northern California (1713)
Ohio (113)
Oklahoma (9)
Oregon (21)
Pennsylvania (751)
Puerto Rico (6)
Rhode Island (19)
South America (217)
South Carolina (4)
Southern California (1498)
Tennessee (26)
Texas (460)
United States (13470)
Utah (58)
Virginia (79)
Washington D.C. (31)
Washington State (355)
Wisconsin (15)
274,342 Results for "summit therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lung cancer
Summit’s Bispecific Beats Yet Another Cancer Med, Pressuring Keytruda’s ‘Supremacy’
Analysts at BMO Capital Markets expect Summit and Akeso’s HARMONi-6 readout to put some pressure on Merck and its blockbuster biologic Keytruda.
April 23, 2025
·
2 min read
·
Tristan Manalac
Cancer
Summit, Akeso’s Keytruda Challenger Wins Chinese OK as US Approval Questions Linger
With ivonescimab’s data coming solely from China, its prospects in the U.S., where Summit owns the rights, remain up in the air.
April 28, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit
April 15, 2025
·
3 min read
Press Releases
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2025
May 1, 2025
·
19 min read
Press Releases
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit
April 16, 2025
·
14 min read
Press Releases
Summit Therapeutics to Host First Quarter 2025 Financial Results & Operational Progress Call on May 1, 2025
April 25, 2025
·
4 min read
Press Releases
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 4, 2025
April 7, 2025
·
4 min read
Press Releases
Robert LaCaze, Innovative Growth-Driver in Oncology, Joins Summit Therapeutics as Chief Commercial Officer
March 18, 2025
·
6 min read
Press Releases
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 21, 2025
March 24, 2025
·
4 min read
Press Releases
Lisata Therapeutics to Present at the 2025 Sequire Investor Summit
January 15, 2025
·
2 min read
1 of 27,435
Next
